BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 16789469)

  • 1. The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas.
    McCarthy EF
    Iowa Orthop J; 2006; 26():154-8. PubMed ID: 16789469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coley's toxins, tumor necrosis factor and cancer research: a historical perspective.
    Wiemann B; Starnes CO
    Pharmacol Ther; 1994; 64(3):529-64. PubMed ID: 7724661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioimmunoadjuvants for the treatment of neoplastic and infectious disease: Coley's legacy revisited.
    Decker WK; Safdar A
    Cytokine Growth Factor Rev; 2009 Aug; 20(4):271-81. PubMed ID: 19656718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Hospital for the Ruptured and Crippled: William Bradley Coley, third Surgeon-in-Chief 1925-1933.
    Levine DB
    HSS J; 2008 Feb; 4(1):1-9. PubMed ID: 18751855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy: A New (and Old) Approach to Treatment of Soft Tissue and Bone Sarcomas.
    Nathenson MJ; Conley AP; Sausville E
    Oncologist; 2018 Jan; 23(1):71-83. PubMed ID: 28935774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coley's toxins in perspective.
    Starnes CO
    Nature; 1992 May; 357(6373):11-2. PubMed ID: 1574121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering Opportunities in Cancer Immunotherapy: After Decades of Missteps and Delays, a Growing Immune-Oncology Market and Improved Cancer Treatment Outcomes Open New Prospects for Biomedical Engineers and Data Scientists.
    Zaharoff DA
    IEEE Pulse; 2018; 9(4):8-11. PubMed ID: 30028678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Talkin' Toxins: From Coley's to Modern Cancer Immunotherapy.
    Carlson RD; Flickinger JC; Snook AE
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32283684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The response of urological tumours to immunotherapy.
    Gkialas I; Kalantzis A; Lykourinas M
    J BUON; 2005; 10(3):329-36. PubMed ID: 17357186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [History of Immuno-therapy -  from Coley Toxins to Check-points of the Immune Reaction].
    Říhová B; Šťastný M
    Klin Onkol; 2015; 28 Suppl 4():4S8-14. PubMed ID: 26647883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous regression: a hidden treasure buried in time.
    Hoption Cann SA; van Netten JP; van Netten C; Glover DW
    Med Hypotheses; 2002 Feb; 58(2):115-9. PubMed ID: 11812185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coley's toxin: historical perspective.
    Bickels J; Kollender Y; Merinsky O; Meller I
    Isr Med Assoc J; 2002 Jun; 4(6):471-2. PubMed ID: 12073431
    [No Abstract]   [Full Text] [Related]  

  • 13. Bacterial Therapy of Cancer: Promises, Limitations, and Insights for Future Directions.
    Kramer MG; Masner M; Ferreira FA; Hoffman RM
    Front Microbiol; 2018; 9():16. PubMed ID: 29472896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coley toxins immunotherapy: a retrospective review.
    Richardson MA; Ramirez T; Russell NC; Moye LA
    Altern Ther Health Med; 1999 May; 5(3):42-7. PubMed ID: 10234867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fever in Cancer Treatment: Coley's Therapy and Epidemiologic Observations.
    Kienle GS
    Glob Adv Health Med; 2012 Mar; 1(1):92-100. PubMed ID: 24278806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fever and cancer in perspective.
    Hobohm U
    Cancer Immunol Immunother; 2001 Oct; 50(8):391-6. PubMed ID: 11726133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging role of immunotherapy for the treatment of sarcoma.
    Klemen ND; Kelly CM; Bartlett EK
    J Surg Oncol; 2021 Mar; 123(3):730-738. PubMed ID: 33259653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. William B. Coley: His Hypothesis, His Toxin, and the Birth of Immunotherapy.
    Loughlin KR
    Urol Clin North Am; 2020 Nov; 47(4):413-417. PubMed ID: 33008492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the influence of bacterial infection and of bacterial products (Coley's toxins) on malignant tumors in man; a critical analysis of 30 inoperable cases treated by Coley's mixed toxins, in which diagnosis was confirmed by microscopic examination selected for special study.
    NAUTS HC; FOWLER GA; BOGATKO FH
    Acta Med Scand Suppl; 1953; 276():1-103. PubMed ID: 13039964
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunity over inability: The spontaneous regression of cancer.
    Jessy T
    J Nat Sci Biol Med; 2011 Jan; 2(1):43-9. PubMed ID: 22470233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.